Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischemic stroke (Cochrane review).
Counsell
Carl
C
Department of Medicine and Therapeutics, University of Aberdeen, UK.
Sandercock
Peter
P
D000208:Acute Disease; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D002545:Brain Ischemia / Q000150:complications / Q000188:drug therapy*; D002809:Chondroitin Sulfates / Q000009:adverse effects / Q000627:therapeutic use; D016208:Databases, Factual; D003871:Dermatan Sulfate / Q000009:adverse effects / Q000627:therapeutic use; D004338:Drug Combinations; D017984:Enoxaparin / Q000009:adverse effects / Q000627:therapeutic use; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects / Q000627:therapeutic use*; D006496:Heparinoids / Q000009:adverse effects / Q000627:therapeutic use*; D006497:Heparan Sulfate / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D016017:Odds Ratio; D011655:Pulmonary Embolism / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D020521:Stroke / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000517:prevention & control
D000925:Anticoagulants; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D004338:Drug Combinations; D017984:Enoxaparin; D006493:Heparin; D006495:Heparin, Low-Molecular-Weight; D006496:Heparinoids; D006497:Heparan Sulfate; C035838:danaparoid